L302-1473 Screening compound: 1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-3,3-dimethyl-N-[(oxolan-2-yl)methyl]-2,3-dihydro-1H-indole-5-sulfonamide

L302-1473 Screening compound: 1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-3,3-dimethyl-N-[(oxolan-2-yl)methyl]-2,3-dihydro-1H-indole-5-sulfonamide
L302-1473 Screening compound: 1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-3,3-dimethyl-N-[(oxolan-2-yl)methyl]-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L302-1473
1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-3,3-dimethyl-N-[(oxolan-2-yl)methyl]-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L302-1473

Molecular Formula

C24H30N2O5S (C24 H30 N2 O5 S)

Compound Name

1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-3,3-dimethyl-N-[(oxolan-2-yl)methyl]-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

1-cyclopropanecarbonyl-N-[(furan-2-yl)methyl]-33-dimethyl-N-[(oxolan-2-yl)methyl]-23-dihydro-1H-indole-5-sulfonamide

SMILES

CC(C)(C1)c(cc(cc2)S(N(CC3OCCC3)Cc3ccco3)(=O)=O)c2N1C(C1CC1)=O

InChI

InChI=1S/C24H30N2O5S/c1-24(2)16-26(23(27)17-7-8-17)22-10-9-20(13-21(22)24)32(28,29)25(14-18-5-3-11-30-18)15-19-6-4-12-31-19/h3,5,9-11,13,17,19H,4,6-8,12,14-16H2,1-2H3/t19-/m1/s1

InChI Key

RFJYIKFVWUFBQP-LJQANCHMSA-N

MDL Number (MFCD)

MFCD27243003

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

458.58

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.817

Distribution Coefficient, logD

3.817

Water Solubility, LogSw

-3.92

Polar Surface Area

63.881

Acid Dissociation Constant (pKa)

21.07

Base Dissociation Constant (pKb)

-2.56

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

54.20

L302-1473 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with L302-1473 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L302-1473?
Check Price and Availability of L302-1473, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L302-1473 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L302-1473
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L302-1473
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L302-1473 available by request